Startups
D-Sight is a spin-off company from Vall d’Hebron Institute of Research (VHIR) lead by an experienced and committed team dedicated to the discovery and development of new innovative treatments for neurodegenerative diseases of the retina. We are shaping the future of retinal diseases treatment with our first product in development: a first-in-class eye drop formulation for the prevention and treatment of diabetic retinopathy in its early stages.
Overview
Location
Spain, Catalonia, Barcelona
Employees
1-10
Founded date
2023
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 12, 2024 | Top 15 de startups de eHealth a tener en cuenta en 2024 | El sector de la salud es, dentro del ecosistema startup, uno de los más innovadores y con más retos por delante en cuanto a digitalización. Y es que al igual que los consumidores han cambiado sus hábitos fuera de esta industria, esperan tam... |
| D-Sight | “DSight | innovative treatments for retinal neurodegenerative diseases” |
Reviews 0
FAQ about D-Sight S.L.
When was D-Sight S.L. founded?
D-Sight S.L. was founded in 2023.
What has the press written about D-Sight S.L.?
Parsers VC has collected 3 articles mentioning D-Sight S.L., among them “Top 15 de startups de eHealth a tener en cuenta en 2024” (Feb 12, 2024) and “D-Sight”.
Is D-Sight S.L. still active?
Yes, D-Sight S.L. is active; its latest activity on Parsers VC dates from Aug 28, 2024.